Unequal Placental Sharing in Monochorionic Diamniotic Twins: an Observational Study

Universitaire Ziekenhuizen KU Leuven393 enrolled

Overview

This is an observational study in 3 cohorts of monochorionic diamniotic (MCDA) twins. The aim of the study is to assess whether unequal placental sharing can be predicted in pregnancy and whether it is predictive of pregnancy outcome.

In all cohorts, serial ultrasound will be performed during pregnancy. MRI will be offered once during pregnancy. After delivery, placental examination will be performed. In unselected MCDA twins, the investigators will assess the relationship between unequal placental sharing and the risk of fetal or neonatal loss. The investigators will also establish whether umbilical vein measurements or MRI can be used to predict placental sharing. In cases complicated by twin-to-twin transfusion syndrome (TTTS), the investigators will look at the association between unequal placental sharing and intrauterine fetal demise after laser surgery. In cases complicated by selective intra-uterine growth restriction (sIUGR), the the relationship between unequal placental sharing and the risk of fetal or neonatal loss and birth prior to 34 weeks will be assessed. Furthermore, data on neurological outcome at 2 years of age in all cohorts will be collected.

Study Type

OBSERVATIONAL

Enrollment

393

Conditions

Monochorionic Twins

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * MCDA cohort * Ongoing monochorionic diamniotic twin pregnancy between 11 and 14 weeks, as determined by the crown rump length of the larger twin in spontaneous conceptions and by the date of insemination or embryonic age at replacement in pregnancies resulting from subfertility treatment * Women aged 18 years or more, who are able to consent * Written informed consent to participate in this study, forms being approved by the Ethical Committees * TTTS cohort * Monochorionic diamniotic twin pregnancy, with gestational age defined in the first trimester as mentioned above * Complicated by TTTS according to the definition used in the Quintero staging of TTTS (DVP of donor \< 2 cm and DVP of receptor \> 8 cm before 20 weeks or \> 10 cm after 20 weeks * Undergoing laser surgery for TTTS * Women aged 18 years or more, who are able to consent * Written informed consent to participate in this study, forms being approved by the Ethical Committees * sIUGR cohort * Monochorionic diamniotic twin pregnancy, with gestational age defined in the first trimester as mentioned above * Complicated by sIUGR defined as a discordance in EFW of ≥ 20%, with the percentage of discordance being calculated as (EFW larger twin - EFW smaller twin)/EFW larger twin x 100. * Women aged 18 years or more, who are able to consent * Written informed consent to participate in this study, forms being approved by the Ethical Committees Exclusion Criteria: * Age \< 18 years * Inability to consent

Locations (1)

UZ Leuven

Leuven, Belgium

RECRUITING

Outcomes

Primary Outcomes

MCDA cohort: the association between unequal sharing and risk of fetal or neonatal loss (assessed by review of obstetric and pediatric records)

Time frame: 2 weeks after expected date of birth

TTTS cohort: the association between unequal sharing and intrauterine fetal death (assessed by review of obstetric records)

Time frame: 2 weeks after expected date of birth

sIUGR cohort: the association between unequal sharing and risk of fetal or neonatal loss and birth prior to 34 weeks (assessed by review of obstetric and pediatric records)

Time frame: 2 weeks after expected date of birth

Secondary Outcomes

The correlation between prenatal ultrasound and MRI variables and placental sharing as assessed by postnatal imaging (all cohorts)

Time frame: 2 weeks after expected date of birth

The association between unequal sharing and intact survival (all cohorts) (assessed by review of obstetric and pediatric records and parent questionnaire)

Time frame: 2 years after expected date of birth

Central Contacts

Isabel Couck

CONTACT

+32 16 34 22 94 isabel.couck@uzleuven.be

Liesbeth Lewi

CONTACT

liesbeth.lewi@uzleuven.be

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.